Esther Drill

机构：Memorial Sloan Kettering Cancer Center · ORCID：0000-0002-3315-4538

发表论文 219 篇 · 总被引 9503 次 · h-index 31

代表论文

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma (2024 · Journal of Clinical Oncology · 被引 20)
Pembrolizumab Maintenance Instead of Autologous Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma in Complete Response after Pembrolizumab, Gemcitabine, Vinorelbine, and Liposomal Doxorubicin (2024 · Blood · 被引 12)
Treatment and outcomes of progression of disease post–CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis (2025 · Blood Advances · 被引 7)
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial (2024 · Nature Medicine · 被引 4)
Pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter, Phase 2 trial (2025 · Blood · 被引 3)
Treatment Patterns and Outcomes Following Progression of Disease Post-CAR-T Therapy in Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter Analysis (2024 · Blood · 被引 3)